Nordic Life Science Days
Brinter unveils ‘very versatile’ multi-material 3D bioprinter
Brinter recently introduced a multi-material ‘3D bioprinter’ to support biopharmaceutical research and development, including toxicity testing.
Nordic Life Science Days
Brinter recently introduced a multi-material ‘3D bioprinter’ to support biopharmaceutical research and development, including toxicity testing.
US FDA grants first approval for a monkeypox vaccine and hands Bavarian Nordic a priority review voucher at the same time.
GSK’s biopharmaceutical manufacturing facility will be focused on the company’s pipeline of biologic medicines, including gene therapies, and vaccines.